Keywords: Ranbaxy, Second-quarter 2011 financial results, Daiichi Sankyo
Ranbaxy posts 2nd-qtr 2011 net profit down 25%
Article | 07 August 2011
India’s largest drugmaker Ranbaxy (RANB: BO) reported second-quarter 2011 financial results, with sales up a slight 1.1% at 20.59 billion rupees ($461 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
